HESI RN
Care Hope College RN HESI Pharmacology Questions
Extract:
Question 1 of 5
A patient in a residential treatment facility uses a fluticasone propionate and salmeterol discus inhalation system to manage asthma. This system delivers an inhaled powdered form of these combined medications. What instruction should the nurse provide to this patient’s caregivers?
Correct Answer: B
Rationale: Fluticasone/salmeterol is a maintenance therapy, used twice daily (
B). Exhaling into the mouthpiece (
A) is incorrect; inhalation is required. Hypotension (
C) isn’t a common side effect. It’s not for acute attacks (
D), which require rescue inhalers.
Question 2 of 5
When administering medications to a group of patients, which patient should the nurse closely monitor for the development of acute kidney injury (AKI)?
Correct Answer: A
Rationale: Vancomycin (
A) is nephrotoxic and requires monitoring for AKI, especially with high doses or prolonged use. Sucralfate (
B) protects the stomach, not kidneys. Lorazepam (
C) and digoxin (
D) have minimal renal toxicity risks.
Question 3 of 5
A client with atrial fibrillation has been prescribed dabigatran. What instruction should the nurse include in this client’s teaching plan?
Correct Answer: B
Rationale: Dabigatran increases bleeding risk; avoiding NSAIDs (
B) reduces this risk. Spinach (
A) affects warfarin, not dabigatran. Routine bleeding tests (
C) aren’t required for dabigatran. Antidotes (
D) like idarucizumab are hospital-administered, not kept at home.
Question 4 of 5
A client with chemotherapy-induced nausea receives a prescription for metoclopramide. Which adverse effect is most important for the nurse to report?
Correct Answer: D
Rationale: Involuntary movements (
D), such as tardive dyskinesia, are a serious, potentially irreversible side effect of metoclopramide, requiring immediate reporting. Diarrhea (
A) and irritability (
B) are less severe. Nausea (
C) is the treated condition, not an adverse effect.
Question 5 of 5
A client with Parkinson’s disease who is taking carbidopa/levodopa reports that the urine appears to be darker in color. What action should the nurse take?
Correct Answer: B
Rationale: Carbidopa/levodopa can darken urine (
B), a benign side effect. Increased fluids (
A) or urine culture (
C) are unnecessary unless other symptoms arise. Measuring output (
D) doesn’t address the color change.